Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 275

1.

The American Orthopaedic Association's Own the Bone® database: a national quality improvement project for the treatment of bone health in fragility fracture patients.

Carlson BC, Robinson WA, Wanderman NR, Nassr AN, Huddleston PM 3rd, Yaszemski MJ, Currier BL, Jeray KJ, Kirk KL, Bunta AD, Murphy S, Patel B, Watkins CM, Sietsema DL, Edwards BJ, Tosi LL, Anderson PA, Freedman BA.

Osteoporos Int. 2018 Sep;29(9):2101-2109. doi: 10.1007/s00198-018-4585-7. Epub 2018 Jun 1.

PMID:
29858634
2.

Comparison of Calcaneal Exposure Through the Extensile Lateral and Sinus Tarsi Approaches.

Bedigrew KM, Blair JA, Possley DR, Kirk KL, Hsu JR.

Foot Ankle Spec. 2018 Apr;11(2):142-147. doi: 10.1177/1938640017713616. Epub 2017 Jun 9.

PMID:
28597687
3.

Comparative Study of Assisted Ambulation and Perceived Exertion With the Wheeled Knee Walker and Axillary Crutches in Healthy Subjects.

Kocher BK, Chalupa RL, Lopez DM, Kirk KL.

Foot Ankle Int. 2016 Nov;37(11):1232-1237. Epub 2016 Aug 11.

PMID:
27521354
4.

Analysis of cystic fibrosis-associated P67L CFTR illustrates barriers to personalized therapeutics for orphan diseases.

Sabusap CM, Wang W, McNicholas CM, Chung WJ, Fu L, Wen H, Mazur M, Kirk KL, Collawn JF, Hong JS, Sorscher EJ.

JCI Insight. 2016 Sep 8;1(14). pii: e86581.

5.

Robust Stimulation of W1282X-CFTR Channel Activity by a Combination of Allosteric Modulators.

Wang W, Hong JS, Rab A, Sorscher EJ, Kirk KL.

PLoS One. 2016 Mar 23;11(3):e0152232. doi: 10.1371/journal.pone.0152232. eCollection 2016.

6.

Channel Gating Regulation by the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) First Cytosolic Loop.

Ehrhardt A, Chung WJ, Pyle LC, Wang W, Nowotarski K, Mulvihill CM, Ramjeesingh M, Hong J, Velu SE, Lewis HA, Atwell S, Aller S, Bear CE, Lukacs GL, Kirk KL, Sorscher EJ.

J Biol Chem. 2016 Jan 22;291(4):1854-65. doi: 10.1074/jbc.M115.704809. Epub 2015 Dec 1.

7.

Long-range coupling between the extracellular gates and the intracellular ATP binding domains of multidrug resistance protein pumps and cystic fibrosis transmembrane conductance regulator channels.

Wei S, Roessler BC, Icyuz M, Chauvet S, Tao B, Hartman JL 4th, Kirk KL.

FASEB J. 2016 Mar;30(3):1247-62. doi: 10.1096/fj.15-278382. Epub 2015 Nov 25.

8.

An electrostatic interaction at the tetrahelix bundle promotes phosphorylation-dependent cystic fibrosis transmembrane conductance regulator (CFTR) channel opening.

Wang W, Roessler BC, Kirk KL.

J Biol Chem. 2014 Oct 31;289(44):30364-78. doi: 10.1074/jbc.M114.595710. Epub 2014 Sep 4.

9.

Conserved allosteric hot spots in the transmembrane domains of cystic fibrosis transmembrane conductance regulator (CFTR) channels and multidrug resistance protein (MRP) pumps.

Wei S, Roessler BC, Chauvet S, Guo J, Hartman JL 4th, Kirk KL.

J Biol Chem. 2014 Jul 18;289(29):19942-57. doi: 10.1074/jbc.M114.562116. Epub 2014 May 29.

10.

Can an integrated orthotic and rehabilitation program decrease pain and improve function after lower extremity trauma?

Bedigrew KM, Patzkowski JC, Wilken JM, Owens JG, Blanck RV, Stinner DJ, Kirk KL, Hsu JR; Skeletal Trauma Research Consortium (STReC).

Clin Orthop Relat Res. 2014 Oct;472(10):3017-25. doi: 10.1007/s11999-014-3609-7.

11.
12.

Being positive: revisiting the elevated sodium permeability hypothesis in cystic fibrosis.

Kirk KL.

J Physiol. 2013 Aug 1;591(15):3675-6. doi: 10.1113/jphysiol.2013.260406. No abstract available.

13.

Comparison of functional outcomes following bridge synostosis with non-bone-bridging transtibial combat-related amputations.

Keeling JJ, Shawen SB, Forsberg JA, Kirk KL, Hsu JR, Gwinn DE, Potter BK.

J Bone Joint Surg Am. 2013 May 15;95(10):888-93. doi: 10.2106/JBJS.L.00423.

PMID:
23677355
14.

Converting nonhydrolyzable nucleotides to strong cystic fibrosis transmembrane conductance regulator (CFTR) agonists by gain of function (GOF) mutations.

Okeyo G, Wang W, Wei S, Kirk KL.

J Biol Chem. 2013 Jun 14;288(24):17122-33. doi: 10.1074/jbc.M112.442582. Epub 2013 Apr 25.

15.

Treatment of open proximal femoral fractures sustained in combat.

Mack AW, Freedman BA, Groth AT, Kirk KL, Keeling JJ, Andersen RC.

J Bone Joint Surg Am. 2013 Feb 6;95(3):e13(1-8). doi: 10.2106/JBJS.K.01568.

PMID:
23389793
16.

The CFTR ion channel: gating, regulation, and anion permeation.

Hwang TC, Kirk KL.

Cold Spring Harb Perspect Med. 2013 Jan 1;3(1):a009498. doi: 10.1101/cshperspect.a009498.

17.

Quantification of posterior ankle exposure through an achilles tendon-splitting versus posterolateral approach.

Patzkowski JC, Kirk KL, Orr JD, Waterman BR, Kirby JM, Hsu JR.

Foot Ankle Int. 2012 Oct;33(10):900-4. doi: DOI: 10.3113/FAI.2012.0900.

PMID:
23050716
18.

Deployment after limb salvage for high-energy lower-extremity trauma.

Patzkowski JC, Owens JG, Blanck RV, Kirk KL, Hsu JR; Skeletal Trauma Research Consortium (STReC).

J Trauma Acute Care Surg. 2012 Aug;73(2 Suppl 1):S112-5.

PMID:
22847079
19.

Management of posttraumatic osteoarthritis with an integrated orthotic and rehabilitation initiative.

Patzkowski JC, Owens JG, Blanck RV, Kirk KL, Hsu JR; Skeletal Trauma Research Consortium.

J Am Acad Orthop Surg. 2012;20 Suppl 1:S48-53. doi: 10.5435/JAAOS-20-08-S48.

PMID:
22865137
20.

A comparison of limb-socket kinematics of bone-bridging and non-bone-bridging wartime transtibial amputations.

Tucker CJ, Wilken JM, Stinner PD, Kirk KL.

J Bone Joint Surg Am. 2012 May 16;94(10):924-30. doi: 10.2106/JBJS.K.00605.

PMID:
22617921
21.

Comparative effect of orthosis design on functional performance.

Patzkowski JC, Blanck RV, Owens JG, Wilken JM, Kirk KL, Wenke JC, Hsu JR; Skeletal Trauma Research Consortium.

J Bone Joint Surg Am. 2012 Mar 21;94(6):507-15. doi: 10.2106/JBJS.K.00254.

PMID:
22437999
22.

Incidence of osteochondral lesions of the talus in the United States military.

Orr JD, Dawson LK, Garcia EJ, Kirk KL.

Foot Ankle Int. 2011 Oct;32(10):948-54.

PMID:
22224323
23.
24.

Partial foot amputations in the combat wounded.

Kirk KL, Jones EM, Potter BK, Osborn PM, Ficke JR.

J Surg Orthop Adv. 2011 Spring;20(1):19-22.

PMID:
21477528
25.

"March fractures" on a female military recruit.

Duran-Stanton AM, Kirk KL.

Mil Med. 2011 Jan;176(1):53-5.

PMID:
21305960
27.

Prevalence of late amputations during the current conflicts in Afghanistan and Iraq.

Stinner DJ, Burns TC, Kirk KL, Scoville CR, Ficke JR, Hsu JR; Late Amputation Study Team.

Mil Med. 2010 Dec;175(12):1027-9.

PMID:
21265314
28.

Oxidative inactivation of the lipid phosphatase phosphatase and tensin homolog on chromosome ten (PTEN) as a novel mechanism of acquired long QT syndrome.

Wan X, Dennis AT, Obejero-Paz C, Overholt JL, Heredia-Moya J, Kirk KL, Ficker E.

J Biol Chem. 2011 Jan 28;286(4):2843-52. doi: 10.1074/jbc.M110.125526. Epub 2010 Nov 20.

29.

Minimally invasive shortening humeral osteotomy to salvage a through-elbow amputation.

Beltran MJ, Kirk KL, Hsu JR.

Mil Med. 2010 Sep;175(9):693-6.

PMID:
20882935
30.

CFTR channels and wound healing. Focus on "Cystic fibrosis transmembrane conductance regulator is involved in airway epithelial wound repair".

Kirk KL.

Am J Physiol Cell Physiol. 2010 Nov;299(5):C888-90. doi: 10.1152/ajpcell.00313.2010. Epub 2010 Aug 11. No abstract available.

31.

Evidence that histidine protonation of receptor-bound anthrax protective antigen is a trigger for pore formation.

Wimalasena DS, Janowiak BE, Lovell S, Miyagi M, Sun J, Zhou H, Hajduch J, Pooput C, Kirk KL, Battaile KP, Bann JG.

Biochemistry. 2010 Aug 24;49(33):6973-83. doi: 10.1021/bi100647z.

32.

Cross-linking of ΔF508-CFTR promotes its trafficking to the plasma membrane.

Bernard K, Kirk KL.

Channels (Austin). 2010 Jul-Aug;4(4):251-4. Epub 2010 Jul 23.

33.

Posterior thigh abscess as a complication of continuous popliteal nerve catheter.

Tucker CJ, Kirk KL, Ficke JR.

Am J Orthop (Belle Mead NJ). 2010 Mar;39(3):E25-7.

PMID:
20463991
34.

The mangled foot and leg: salvage versus amputation.

Shawen SB, Keeling JJ, Branstetter J, Kirk KL, Ficke JR.

Foot Ankle Clin. 2010 Mar;15(1):63-75. doi: 10.1016/j.fcl.2009.11.005. Review.

PMID:
20189117
35.

Compartment syndrome and lower-limb fasciotomies in the combat environment.

Kirk KL, Hayda R.

Foot Ankle Clin. 2010 Mar;15(1):41-61. doi: 10.1016/j.fcl.2009.11.003. Review.

PMID:
20189116
36.

ATP-independent CFTR channel gating and allosteric modulation by phosphorylation.

Wang W, Wu J, Bernard K, Li G, Wang G, Bevensee MO, Kirk KL.

Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3888-93. doi: 10.1073/pnas.0913001107. Epub 2010 Feb 3.

37.

Return to duty rate of amputee soldiers in the current conflicts in Afghanistan and Iraq.

Stinner DJ, Burns TC, Kirk KL, Ficke JR.

J Trauma. 2010 Jun;68(6):1476-9. doi: 10.1097/TA.0b013e3181bb9a6c.

PMID:
20068483
38.

Reverse sural artery flap for reconstruction of blast injuries of the foot and ankle.

Orr J, Kirk KL, Antunez V, Ficke J.

Foot Ankle Int. 2010 Jan;31(1):59-64. doi: 10.3113/FAI.2010.0059.

PMID:
20067724
39.

Functional outcome of multiligamentous knee injuries treated arthroscopically in active duty soldiers.

Ross AE, Taylor KF, Kirk KL, Murphy KP.

Mil Med. 2009 Oct;174(10):1113-7.

PMID:
19891227
40.

Structural basis of the selectivity of the beta(2)-adrenergic receptor for fluorinated catecholamines.

Pooput C, Rosemond E, Karpiak J, Deflorian F, Vilar S, Costanzi S, Wess J, Kirk KL.

Bioorg Med Chem. 2009 Dec 1;17(23):7987-92. doi: 10.1016/j.bmc.2009.10.015. Epub 2009 Oct 13.

41.

Curcumin cross-links cystic fibrosis transmembrane conductance regulator (CFTR) polypeptides and potentiates CFTR channel activity by distinct mechanisms.

Bernard K, Wang W, Narlawar R, Schmidt B, Kirk KL.

J Biol Chem. 2009 Nov 6;284(45):30754-65. doi: 10.1074/jbc.M109.056010. Epub 2009 Sep 9.

42.

An Enantioselective Synthesis of (S)-4-Fluorohistidine.

Hajduch J, Cramer JC, Kirk KL.

J Fluor Chem. 2008 Sep;129(9):807-810.

43.

Editorial for special issue of JFC on Biomedicinal Chemistry.

Kirk KL.

J Fluor Chem. 2008 Sep;129(9):730. No abstract available.

45.

Molecular recognition in the P2Y(14) receptor: Probing the structurally permissive terminal sugar moiety of uridine-5'-diphosphoglucose.

Ko H, Das A, Carter RL, Fricks IP, Zhou Y, Ivanov AA, Melman A, Joshi BV, Kovác P, Hajduch J, Kirk KL, Harden TK, Jacobson KA.

Bioorg Med Chem. 2009 Jul 15;17(14):5298-311. doi: 10.1016/j.bmc.2009.05.024. Epub 2009 May 15.

46.

Synthesis of (E)- and (Z)-alpha,beta-Difluorourocanic Acid.

Hajduch J, Dolenský B, Yoshida S, Fan J, Kirk KL.

J Fluor Chem. 2008 Feb;129(2):112-118.

47.

Monitoring anthrax toxin receptor dissociation from the protective antigen by NMR.

Rajapaksha M, Eichler JF, Hajduch J, Anderson DE, Kirk KL, Bann JG.

Protein Sci. 2009 Jan;18(1):17-23. doi: 10.1002/pro.26.

48.

Synthetic Studies of 3-(3-Fluorooxindol-3-yl)-l-alanine.

Fujiwara T, Yin B, Jin M, Kirk KL, Takeuchi Y.

J Fluor Chem. 2008;129(9):829-835.

49.

John W. Daly - An Appreciation.

Jacobson KA, Kirk KL.

Heterocycles. 2009;79(1):61-71.

50.

ATFL elongation after Brostrom procedure: a biomechanical investigation.

Kirk KL, Campbell JT, Guyton GP, Parks BG, Schon LC.

Foot Ankle Int. 2008 Nov;29(11):1126-30. doi: 10.3113/FAI.2008.1126.

PMID:
19026207

Supplemental Content

Support Center